Urologic Neoplasms: all 143 studies
Page 2 of 2. Open to participants first (42), then studies with results posted, then the rest; newest registration first within each.
- A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine TumorsStatus unknownNCT04207463Phase 2
- Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial CancerCompletedNCT04052113
- Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air SamplesTerminatedNCT03721042Not applicable
- Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneCompletedNCT03602079Phase 1/2
- Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer ImmunotherapyCompletedNCT03595813Not applicable
- Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer:CompletedNCT03548688
- Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell CarcinomaActive, not recruitingNCT03541902Phase 2
- Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney CancerCompletedNCT03473730Early Phase 1
- Pre-Operative Single Shot Rectus Sheath BlockCompletedNCT03458598Not applicable
- Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NTActive, not recruitingNCT03435952Phase 1
- Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsTerminatedNCT03420963Phase 1
- Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking StudyCompletedNCT03410641
- Unmet Supportive Care Needs in Bladder Cancer Patients Undergoing Radical CystectomyCompletedNCT03307200
- Optimized Perioperative Antibiotic Prophylaxis in Radical CystectomyCompletedNCT03305627Not applicable
- A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial CancerTerminatedNCT03288545Phase 1/2
- Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot StudyCompletedNCT03245788Not applicable
- Oral Supplementation to Enhance Recovery Pilot StudyCompletedNCT03204266Early Phase 1
- INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological CancersCompletedNCT03071328Early Phase 1
- CLE Characteristics of Upper Urinary Tract Urothelial CarcinomaCompletedNCT03013920
- A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic SurgeryCompletedNCT03010813Not applicable
- Lenvatinib and Capecitabine in Patients With Advanced MalignanciesWithdrawnNCT02915172Phase 1
- Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC PatientsCompletedNCT02891460Not applicable
- Safety and Tolerability of Recombinant Humanized Anti-PD-1 Monoclonal Antibody Toripalimab for Patients With Advanced Solid TumorsCompletedNCT02836795Phase 1
- Correlation Between Intraocular Pressure Measurement by Tomometer and Anterior Chamber Depth Measurement by UltrasoundTerminatedNCT02818530Not applicable
- Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant CancersCompletedNCT02675829Phase 2
- A Study of Varlilumab and Atezolizumab in Patients With Advanced CancerTerminatedNCT02543645Phase 1
- A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell CarcinomaTerminatedNCT02386111Phase 1
- Registry for Treatment of Upper Urinary Tract TumoursStatus unknownNCT02281188
- Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract TumorsCompletedNCT02276924Not applicable
- SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study IWithdrawnNCT02254915Phase 3
- Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign DiseaseTerminatedNCT01552434Phase 1
- A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder CancerCompletedNCT01454089Phase 2
- Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate CancerTerminatedNCT01155791Phase 1
- Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder CancerTerminatedNCT00384891Phase 3
- IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and MelanomaStatus unknownNCT00294476Phase 2
- Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate CancerTerminatedNCT00226954Phase 2
- 2nd Line Gemcitabine Monotherapy for Transitional Cell Carcinoma of Urothelium (TCC) After CDDP RegimenCompletedNCT00191971Phase 2
- Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial CancerCompletedNCT00151034Phase 2
- Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) CancerCompletedNCT00134186Phase 2
- A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the UrotheliumCompletedNCT00035061Phase 2
- A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00034593Phase 2
- Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the UrotheliumCompletedNCT00034177Phase 2
- Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of SamplesCompletedNCT00001814